Bioavailability Study of Fexofenadine HCl New Formulation Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

May 8, 2024

Study Completion Date

May 23, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Fexofenadine HCl Coated tablet

Film-coated tablet.

DRUG

Fexofenadine HCl New Formulation Tablet

New formulation tablet.

Trial Locations (1)

Syneos Health Clinic inc., Québec

All Listed Sponsors

lead

Opella Healthcare Group SAS, a Sanofi Company

INDUSTRY

NCT06284902 - Bioavailability Study of Fexofenadine HCl New Formulation Tablet | Biotech Hunter | Biotech Hunter